Stem cells play increasingly prominent roles in tissue engineering and regenerative
medicine. Pluripotent embryonic stem (ES) cells theoretically allow every cell type in the …

The primary sources of industrial collagens are calf skin and bone. However, these carry a
high risk of bovine spongiform encephalopathy or transmissible spongiform …

In an effort to improve the long-term patency of vascular prostheses several groups now
advocate seeding autologous endothelial cells (ECs) onto the lumen of the vessel prior to …

Artificial vascular grafts consisting of ePTFE have been mainly used in clinics for the
treatment of cardiovascular disease. However, artificial grafts can become clogged after a …

Tissue‐engineered blood vessels have largely relied on inelastic scaffolds or biological
solutions with uncertain long‐term in vivo durability. In this report we present for the first time …

One of the main open issues in modern vascular surgery is the nonbiodegradability of
implants used for stent interventions, which can lead to small caliber‐related thrombosis and …

Heart failure is one of the leading causes of death worldwide. End stage disease often
requires heart transplantation, which is hampered by donor organ shortage. Tissue …

Objective. We are developing a hybrid arterial bypass graft of compliant poly (carbonate–
urea) urethane (MyoLink™), endothelial and smooth muscle cells (SMCs). To enhance …

Conventionally used vascular grafts such as polyester (Dacron) or expanded
polytetrafluoroethylene perform inadequately as small‐diameter vascular bypass grafts …

The use of synthetic polymeric vascular grafts is limited by the thrombogenecity of most
biomaterials. Efforts to reduce thrombogenicity by seeding grafts with endothelial cells, the …